Veeva Systems (NYSE:VEEV – Get Free Report) had its price target increased by equities research analysts at BMO Capital Markets from $175.00 to $270.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “market perform” rating on the technology company’s stock. BMO Capital Markets’ target price points to a potential downside of 5.19% from the stock’s current price.
Several other research analysts have also issued reports on VEEV. Mizuho decreased their price target on shares of Veeva Systems from $295.00 to $270.00 and set an “outperform” rating on the stock in a research report on Thursday, June 4th. Wells Fargo & Company lifted their price objective on Veeva Systems from $317.00 to $320.00 and gave the company an “overweight” rating in a research report on Thursday, June 4th. Evercore restated an “outperform” rating and issued a $185.00 target price on shares of Veeva Systems in a research note on Thursday, June 4th. Truist Financial upped their price target on shares of Veeva Systems from $262.00 to $305.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Barclays raised their price objective on shares of Veeva Systems from $275.00 to $315.00 and gave the company an “overweight” rating in a research report on Thursday. Nineteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $280.58.
View Our Latest Stock Report on Veeva Systems
Veeva Systems Price Performance
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.13. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The business had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. During the same period in the prior year, the firm earned $1.99 earnings per share. The business’s quarterly revenue was up 17.6% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, analysts expect that Veeva Systems will post 6.65 EPS for the current fiscal year.
Insider Activity
In other news, insider Thomas D. Schwenger sold 36,000 shares of the business’s stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $250.23, for a total value of $9,008,280.00. Following the sale, the insider directly owned 19,449 shares in the company, valued at $4,866,723.27. The trade was a 64.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by corporate insiders.
Institutional Trading of Veeva Systems
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. SHP Wealth Management bought a new position in Veeva Systems in the fourth quarter valued at $26,000. Activest Wealth Management increased its position in Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock worth $29,000 after buying an additional 127 shares during the last quarter. MV Capital Management Inc. bought a new position in shares of Veeva Systems in the fourth quarter valued at about $30,000. Reflection Asset Management acquired a new stake in shares of Veeva Systems during the 4th quarter worth about $32,000. Finally, BOK Financial Private Wealth Inc. bought a new stake in shares of Veeva Systems during the 4th quarter worth about $33,000. 88.20% of the stock is currently owned by institutional investors and hedge funds.
Key Headlines Impacting Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Fiscal Q2 revenue rose 17.6% year over year to approximately $928 million, exceeding the $905.4 million analyst consensus. Adjusted earnings of $2.35 per share also surpassed expectations of $2.22 and increased from $1.99 in the prior-year quarter. Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up
- Positive Sentiment: Management raised fiscal 2027 guidance to approximately $3.7 billion in revenue and $9.21 in earnings per share, above consensus estimates of about $3.6 billion and $8.58, respectively. Third-quarter revenue guidance of $932 million to $935 million and EPS guidance of $2.33 to $2.34 also exceeded analyst expectations. Veeva Announces Fiscal 2027 Second Quarter Results
- Positive Sentiment: Strong Vault CRM execution, including a record quarter, supported confidence that Veeva can maintain more than 70% market share. Falcon AI demand is building, with the company expecting its first customer go-lives this year. Veeva Targets Maintaining CRM Share as Falcon Go-Lives Begin
- Positive Sentiment: Several analysts lifted their price targets following the results. RBC raised its target to $325 and kept an outperform rating, while Barclays raised its target to $315 with an overweight rating. Guggenheim and Truist also raised targets to $310 and $305, respectively.
- Neutral Sentiment: Other analysts remained cautious despite raising targets: UBS set a $290 target with a neutral rating, Canaccord set $260 with a hold rating, and Morgan Stanley set $275 with an equal-weight rating. These targets indicate that some firms view much of the earnings optimism as already reflected in the stock.
- Negative Sentiment: At a roughly 50.8 forward? P/E ratio as reported, Veeva carries a premium valuation, leaving the shares sensitive to any slowdown in growth, weaker AI adoption, or future guidance disappointments.
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Recommended Stories
- Five stocks we like better than Veeva Systems
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
- Permian Resources Rally Faces a Test
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
